Human immunodeficiency virus type-1 (HIV-1) integrase catalyzes the irrever
sible insertion of the viral genome into host chromosomal DNA. We have deve
loped a mammalian expression system for the synthesis of authentic HIV-1 in
tegrase in the absence of other viral proteins. Integrase, which bears a N-
terminal phenylalanine, was found to be a short-lived protein in human embr
yo kidney 293T cells. The degradation of integrase could be suppressed by p
roteasome inhibitors. N-terminal phenylalanine is recognized as a degradati
on signal by a ubiquitin-proteasome proteolytic system known as the N-end r
ule pathway. The replacement of N-terminal phenylalanine with methionine, v
aline, or glycine, which are stabilizing residues in the N-end rule, result
ed in metabolically stabilized integrase proteins (half-life of N-terminal
Met-integrase was at least 3 h). Conversely, the substitution of N-terminal
phenylalanine with other destabilizing residues retained the metabolic ins
tability of integrase. These findings indicate that the HIV-1 integrase is
a physiological substrate of the N-end rule. We discuss a possible function
al similarity to the better understood turnover of the bacteriophage Mu tra
nsposase and functions of integrase instability to the maintenance and inte
grity of the host cell genome.